Metraipolis › archive › dc_41309e214736

RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion — Europe PMC PMID:41318657

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41318657
DOI
10.1038/s41419-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-08T03:36:34.640Z
SHA-256 of the archived text
92b566ddc7a46898969fe20ef6055e07aced7c05089942425fbc17c109b4f3ac
Stable URL of this page
https://metraipolis.com/documento/dc_41309e214736

How to cite

RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion — Europe PMC PMID:41318657 — Europe PMC (en), https://europepmc.org/article/MED/41318657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_41309e214736 (Metraipolis archive dc_41309e214736, sha256 92b566ddc7a46898969fe20ef6055e07aced7c05089942425fbc17c109b4f3ac)
BibTeX
@misc{dc41309e214736,
  title = {RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion — Europe PMC PMID:41318657},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41318657},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_41309e214736; sha256 92b566ddc7a46898969fe20ef6055e07aced7c05089942425fbc17c109b4f3ac},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41318657. Agents can read the archived copy with the MCP tool read_document.